The perception of new clinical entities. Synergism between clinical research and marketing research in successful drug development

The most crucial time for close co-operation between clinical research and marketing research is during phase II and early phase III of clinical development.

The Perception of New Clinical Entities. Synergism Between Clinical Research and Marketing Research in Successful Drug Development

Brbel Matiaske (I+G) Germany Raf De Wilde (Janssen Pharmaceutica) Belgium

BACKGROUND AND MAIN OBJECTIVES

The pharmaceutical industry has experienced a global increase in the duration and costs of the clinical development of drugs, which has been aggravated by restrictive pricing policies in almost all countries. This situation and the large gap between the small number of NCEs (New Chemical Entity) which have been introduced in their first market world-wide (for example, in 1995 n = 39, according to SCRIP Review)...

Not a subscriber?

Schedule your live demo with our team today

WARC helps you to plan, create and deliver more effective marketing

  • Prove your case and back-up your idea

  • Get expert guidance on strategic challenges

  • Tackle current and emerging marketing themes

We’re long-term subscribers to WARC and it’s a tool we use extensively. We use it to source case studies and best practice for the purposes of internal training, as well as for putting persuasive cases to clients. In compiling a recent case for long-term, sustained investment in brand, we were able to support key marketing principles with numerous case studies sourced from WARC. It helped bring what could have been a relatively dry deck to life with recognisable brand successes from across a broad number of categories. It’s incredibly efficient to have such a wealth of insight in one place.

Insights Team
Bray Leino

You’re in good company

We work with 80% of Forbes' most valuable brands* and 80% of the world's top top-of-the-class agencies.

* Top 10 brands